The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression

Geoffrey Burnstock1,2,3, Gillian E Knight4

  • 1Autonomic Neuroscience Centre, University College Medical School, Rowland Hill Street, London, NW3 2PF, UK. g.burnstock@ucl.ac.uk.

Purinergic Signalling
|November 23, 2017
PubMed

Insights

The P2X7 receptor (P2X7R) plays a key role in inflammation and cell death. Targeting P2X7R with drugs may offer new treatments for inflammatory diseases, neurodegenerative conditions, and cancer.

Area of Science:

  • Ion channel research
  • Immunology
  • Pharmacology

Background:

  • Seven P2X ion channel nucleotide receptor subtypes are known.
  • P2X7 receptors (P2X7R) possess unique intracellular C-terminal amino acid extensions.
  • P2X7R activation by ATP can lead to cation channel opening or large pore formation.

Purpose of the Study:

  • To explore the pathophysiological roles of P2X7R.
  • To investigate the therapeutic potential of P2X7R antagonists.
  • To discuss P2X7R drug applications in various diseases and tumor progression.

Main Methods:

  • Characterization of P2X7 receptor function.
  • Analysis of ATP concentration-dependent effects on P2X7R.
  • Review of existing literature on P2X7R in disease.

Main Results:

  • Low ATP concentrations activate cation channels, potentially inducing cell proliferation.
  • High ATP concentrations induce large pores, releasing inflammatory cytokines and causing cell death.
  • P2X7R is implicated in inflammatory and immune responses.

Conclusions:

  • P2X7R is a significant regulator of inflammation.
  • P2X7R antagonists show promise for treating inflammatory diseases.
  • Therapeutic strategies targeting P2X7R may be beneficial for neurodegenerative disorders, psychiatric conditions, and cancer.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
62.1K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
Potential Energy00:52

Potential Energy

The energy stored by a structure and location of matter in space is called potential energy. For instance, raising a kettlebell changes its spatial location and increases its potential energy. Similarly, a stretched rubber band contains potential energy which, under certain conditions, can be converted into other forms of energy, such as kinetic energy.
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
42.7K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.9K